Literature DB >> 21127885

Serum concentrations of interleukin-4 and interferon-gamma in relation to severe left ventricular dysfunction in patients with acute myocardial infarction undergoing percutaneous coronary intervention.

Janusz Szkodzinski1, Bartosz Hudzik, Marcin Osuch, Wojciech Romanowski, Bozena Szygula-Jurkiewicz, Lech Polonski, Barbara Zubelewicz-Szkodzinska.   

Abstract

Many studies have suggested an imbalance between proinflammatory and anti-inflammatory markers in acute myocardial infarction (AMI). Interleukin 4 (IL-4) shows mainly anti-inflammatory activities. Interferon-gamma (IFN-γ) is a proinflammatory cytokine secreted by Th1 lymphocytes. Severe systolic left ventricular (LV) dysfunction following AMI is one of the major risk factors for poor prognosis. The aim of this study was to evaluate whether IL-4 and IFN-γ concentrations can serve as the correlates of impaired left ventricular function. Fifty-three patients with AMI were enrolled and divided into two groups depending on their ejection fraction (EF): group 1 with EF ≤ 30% (N = 10) and group 2 with EF >30% (N = 43). All patients underwent coronary angiography followed by percutaneous coronary intervention (PCI). Blood samples were taken (1) before, (2) immediately after, (3) 2 h after, and (4) 72 h after PCI. A receiver-operating characteristic (ROC) analysis was planned to identify possible cutoff values to predict LV dysfunction. There was no sex difference between the two groups. The rate of hypertension and diabetes mellitus was also similar. Median concentrations for IL-4 (pg/ml) were: (1) 13.4 versus 17.2 (p = 0.0001), (2) 16.8 versus 18.6 (p = 0.01), (3) 17.2 versus 17.6 (p = NS), and (4) 17.6 versus 17.2 (p = NS). Median concentrations for IFNγ (pg/ml) were: (1) 0.3 versus 1.9 (p = 0.00001), (2) 2.1 versus 1.6 (p = NS), (3) 0.4 versus 0.9 (p = NS), and (4) 0.9 versus 1.1 (p = NS). The area under the ROC curve (AUC) analysis is presented in the table below. Reported results suggest the high diagnostic value of IL-4 measurements before and immediately after PCI as the correlates of impaired LV dysfunction, whereas only IFN-γ measurement before PCI had a high diagnostic value. Measurements performed later on have no predictive value. Cutoff value AUC Sensitivity (%) Specificity (%) PPV (%) NPV (%) p IL-4 (a) ≤ 15.0 0.89 100 79 52 100 0.0001, IL-4 (b) ≤ 17.2 0.75 100 67 42 100 0.0007, IFNγ (a) ≤ 0.3 0.94 100 91 71 100 0.0001.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21127885     DOI: 10.1007/s00380-010-0076-2

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  29 in total

Review 1.  Anti-inflammatory cytokines.

Authors:  S M Opal; V A DePalo
Journal:  Chest       Date:  2000-04       Impact factor: 9.410

Review 2.  [Gamma-interferon-induced cardiomyopathy during treatment of renal cell carcinoma: a case report].

Authors:  Y Morino; K Hara; H Ushikoshi; K Tanabe; Y Kuroda; T Noguchi; S Ayabe; H Hara; Y Yanbe; K Kozuma; Y Ikari; F Saeki; T Tamura
Journal:  J Cardiol       Date:  2000-07       Impact factor: 3.159

3.  Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure.

Authors:  T Tsutamoto; T Hisanaga; A Wada; K Maeda; M Ohnishi; D Fukai; N Mabuchi; M Sawaki; M Kinoshita
Journal:  J Am Coll Cardiol       Date:  1998-02       Impact factor: 24.094

4.  Effects of interleukin-10 on monocyte/endothelial cell adhesion and MMP-9/TIMP-1 secretion.

Authors:  E Mostafa Mtairag; S Chollet-Martin; M Oudghiri; N Laquay; M P Jacob; J B Michel; L J Feldman
Journal:  Cardiovasc Res       Date:  2001-03       Impact factor: 10.787

5.  Serum interleukin-6 concentration predicts contrast-induced nephropathy in patients undergoing percutaneous coronary intervention.

Authors:  Bartosz Hudzik; Janusz Szkodzinski; Aleksander Danikiewicz; Wojciech Romanowski; Andrzej Lekston; Lech Polonski; Barbara Zubelewicz-Szkodzinska
Journal:  Eur Cytokine Netw       Date:  2010-05-19       Impact factor: 2.737

Review 6.  Basic mechanisms in congestive heart failure. Recognizing the role of proinflammatory cytokines.

Authors:  D L Mann; J B Young
Journal:  Chest       Date:  1994-03       Impact factor: 9.410

7.  Interleukin-2 enhances the cytotoxic activity of circulating natural killer cells in patients with chronic heart failure.

Authors:  Heng-Chen Yao; Shu-Qin Liu; Ke Yu; Min Zhou; Le-Xin Wang
Journal:  Heart Vessels       Date:  2009-07-22       Impact factor: 2.037

8.  Differences in left ventricular function between anterior and inferior myocardial infarction of equivalent enzymatic size.

Authors:  M E Hands; V Antico; P L Thompson; J Hung; J S Robinson; B L Lloyd
Journal:  Int J Cardiol       Date:  1987-11       Impact factor: 4.164

Review 9.  Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling.

Authors:  J N Cohn; R Ferrari; N Sharpe
Journal:  J Am Coll Cardiol       Date:  2000-03-01       Impact factor: 24.094

10.  Expression of interferon-gamma and interleukin-4 production in CD4+ T cells in patients with chronic heart failure.

Authors:  Takashi Fukunaga; Hirofumi Soejima; Atsushi Irie; Koichi Sugamura; Yoko Oe; Tomoko Tanaka; Sunao Kojima; Tomohiro Sakamoto; Michihiro Yoshimura; Yasuharu Nishimura; Hisao Ogawa
Journal:  Heart Vessels       Date:  2007-05-21       Impact factor: 2.037

View more
  12 in total

1.  Systems analysis of gene ontology and biological pathways involved in post-myocardial infarction responses.

Authors:  Nguyen T Nguyen; Merry L Lindsey; Yu-Fang Jin
Journal:  BMC Genomics       Date:  2015-06-11       Impact factor: 3.969

2.  Acute myocardial infarction and cardiogenic shock: prognostic impact of cytokines: INF-γ, TNF-α, MIP-1β, G-CSF, and MCP-1β.

Authors:  R Prondzinsky; S Unverzagt; H Lemm; N Wegener; K Heinroth; U Buerke; M Fiedler; J Thiery; J Haerting; K Werdan; M Buerke
Journal:  Med Klin Intensivmed Notfmed       Date:  2012-07-20       Impact factor: 0.840

3.  Temporal changes in biomarkers and their relationships to reperfusion and to clinical outcomes among patients with ST segment elevation myocardial infarction.

Authors:  Sean van Diepen; Wendimagegn G Alemayehu; Yinggan Zheng; Pierre Theroux; L Kristin Newby; Kenneth W Mahaffey; Christopher B Granger; Paul W Armstrong
Journal:  J Thromb Thrombolysis       Date:  2016-10       Impact factor: 2.300

4.  Plasma levels of sRANKL and OPG are associated with atherogenic cytokines in patients with intermediate cardiovascular risk.

Authors:  Dorette Raaz-Schrauder; Michael G Schrauder; Christian Stumpf; Piotr Lewczuk; Tobias Kilian; Barbara Dietel; Christoph D Garlichs; Christian Schlundt; Stephan Achenbach; Lutz Klinghammer
Journal:  Heart Vessels       Date:  2017-05-31       Impact factor: 2.037

Review 5.  Role of cytokines and inflammation in heart function during health and disease.

Authors:  Monika Bartekova; Jana Radosinska; Marek Jelemensky; Naranjan S Dhalla
Journal:  Heart Fail Rev       Date:  2018-09       Impact factor: 4.214

6.  Effects of Shen-Fu Injection on the Expression of T-Cell-Specific Transcription Factors T-bet/Gata-3 in Porcine Postresuscitation Lung Injury.

Authors:  Wei Gu; Chunsheng Li; Wenpeng Yin; Xiaomin Hou; Da Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-13       Impact factor: 2.629

7.  Bone Marrow Mononuclear Cell Transplantation Restores Inflammatory Balance of Cytokines after ST Segment Elevation Myocardial Infarction.

Authors:  Kirsi Alestalo; Johanna A Miettinen; Olli Vuolteenaho; Heikki Huikuri; Petri Lehenkari
Journal:  PLoS One       Date:  2015-12-21       Impact factor: 3.240

Review 8.  Cytokines as Biomarkers and Their Respective Clinical Cutoff Levels.

Authors:  Rebecca N Monastero; Srinivas Pentyala
Journal:  Int J Inflam       Date:  2017-04-09

9.  Calcium-Sensing Receptor in Human Peripheral Blood T Lymphocytes Is Involved in the AMI Onset and Progression through the NF-κB Signaling Pathway.

Authors:  Jing-Ya Zeng; Jing-Jing Du; Ying Pan; Jian Wu; Hai-Liang Bi; Bao-Hong Cui; Tai-Yu Zhai; Yong Sun; Yi-Hua Sun
Journal:  Int J Mol Sci       Date:  2016-08-24       Impact factor: 5.923

10.  T cell cytokines in the diagnostic of early-onset sepsis.

Authors:  Glenn Malin Froeschle; Tanja Bedke; Michael Boettcher; Samuel Huber; Dominique Singer; Chinedu Ulrich Ebenebe
Journal:  Pediatr Res       Date:  2020-11-10       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.